Impact of substance use on the physical health of patients with bipolar disorder
Article first published online: 5 NOV 2009
© 2009 John Wiley & Sons A/S
Acta Psychiatrica Scandinavica
Volume 121, Issue 6, pages 437–445, June 2010
How to Cite
Garcia-Portilla, M. P., Saiz, P. A., Benabarre, A., Florez, G., Bascaran, M. T., Díaz, E. M., Bousoño, M. and Bobes, J. (2010), Impact of substance use on the physical health of patients with bipolar disorder. Acta Psychiatrica Scandinavica, 121: 437–445. doi: 10.1111/j.1600-0447.2009.01498.x
- Issue published online: 4 MAY 2010
- Article first published online: 5 NOV 2009
- Accepted for publication September 30, 2009
- bipolar disorder;
- substance use;
- metabolic syndrome;
- coronary heart disease;
- cardiovascular mortality risk
Garcia-Portilla MP, Saiz PA, Benabarre A, Florez G, Bascaran MT, Díaz EM, Bousoño M, Bobes J. Impact of substance use on the physical health of patients with bipolar disorder.
Objective: To describe the impact of tobacco, alcohol and cannabis on metabolic profile and cardiovascular risk in bipolar patients.
Method: Naturalistic, cross-sectional, multicenter Spanish study. Current use of tobacco, alcohol and cannabis was determined based on patient self-reports. Metabolic syndrome was defined using the National Health and Nutrition Examination Survey 1999–2000 and the American Heart Association/National Heart, Lung and Blood Institute criteria, and cardiovascular risk using the Framingham and the Systematic Coronary Risk Evaluation functions.
Results: Mean age was 46.6 years, 49% were male. Substance use: 51% tobacco, 13% alcohol and 12.5% cannabis. Patients who reported consuming any substance were significantly younger and a higher proportion was male. After controlling for confounding factors, tobacco was a risk factor for coronary heart disease (CHD) (unstandardized linear regression coefficient 3.47, 95% confidence interval 1.85–5.10).
Conclusion: Substance use, mainly tobacco, was common in bipolar patients. Tobacco use negatively impacted CHD risk.